Get startedLog in
    Picture of Vigil Neuroscience logo

    VIGL — Vigil Neuroscience News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Sanofi to acquire Vigil Neuroscience in $470 million deal

    Picture of Vigil Neuroscience logoVigil Neuroscience
    22/05/2025 24:25
    Corrects to change dateline to May 22; no changes to text

May 22 (Reuters) - Sanofi SASY.PA said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company, for $8 per share in cash, valuing the deal at about $470 million.

 (Reporting by Bipasha Dey in Bengaluru; Editing by Mohammed Safi Shamsi)

 ((Bipasha.Dey@thomsonreuters.com;))

    Recent news on Vigil Neuroscience

    See all news